Emergent BioSolutions Pioneers National Initiative to Enhance NARCAN Access and Opioid Crisis Education,

Published | Modified
CSIMarket Newsroom | CSIMarket.com
Illustrative image

Emergent BioSolutions Takes Bold Steps to Expand NARCAN Access and Combat the Opioid Epidemic’

GAITHERSBURG, Md. In an unwavering commitment to addressing the nation’s opioid epidemic, Emergent BioSolutions Inc. (NYSE: EBS) has amplified its efforts to make NARCAN® Nasal Spray more accessible and to educate the public on its administration. As opioid overdose fatalities have surged in the workplace and beyond, the Maryland-based company is championing collaborative initiatives aimed at opioid emergency preparedness.

Emergent BioSolutions has strategically expanded its distribution network to meet the increasing demand for naloxone, NARCAN’s key ingredient. In August, the company unveiled a NARCANDirect distribution center in Nevada, enabling coast-to-coast delivery. This expansion serves not only to ensure faster and more efficient service to public interest customers but also to equip businesses, facilities, hospitality venues, and other locations with life-saving medications. Such initiatives underscore Emergent’s pivotal role in providing immediate responses to opioid emergencies, which is crucial as workplaces are increasingly facing such incidents.

In March 2024, Emergent’s resolve was further validated when the company joined the White House Challenge to Save Lives from Overdose. This national call to action engages leaders in increasing education and access to opioid overdose reversal medications like NARCAN® Nasal Spray. As part of this effort, Emergent actively collaborates with various stakeholders, setting a precedent for others to follow in combating the opioid crisis through education and readiness.

Education plays a critical role in Emergent’s approach, as evidenced in July 2024 with the launch of their Lay, Spray, Stay public education campaign. This initiative, in collaboration with the SAFE Project an organization dedicated to battling substance use and addiction is designed to prepare individuals nationwide to EBS Featuring Pro Football Hall of Famer Emmitt Smith, the campaign leverages public awareness videos and radio segments to demystify the life-saving technique.

The Lay, Spray, Stay campaign is part of Emergent’s broader Ready to Rescue initiative, aimed at dismantling stigma surrounding opioid poisonings and empowering Americans with the knowledge to act decisively during an overdose. The selection of Emmitt Smith as the campaign’s spokesperson brings both credibility and visibility, connecting with diverse audiences to render the initiative impactful and relatable.

Through strategic expansion and robust educational outreach, Emergent BioSolutions is not only increasing the availability of NARCAN® Nasal Spray but also fostering a culture of preparedness and responsiveness. These efforts reflect a broader societal push to equip locations nationwide with the tools and knowledge necessary to mitigate the opioid crisis. As opioid emergencies continue to challenge communities across the country, Emergent’s proactive stance serves as a beacon of hope, offering tangible solutions in the fight to save lives.

Sources for this article: Based on Emergent Biosolutions Inc ’s official statement and Supply Chain Analysis by CSIMarket.com
For details on how CSIMarket validates financial and corporate news, please review our Editorial Standards & Fact-Checking Policy .
Tags:
#ProductServiceNews, #opioidcrisisEmergentBioAMonthFromAmericanEx, #suppliers, #opioidepidemicIncEarningsAmericanExpressIncTodayReactiveSkinDecontaminationLotion, #whitehouseButHowEmergentBioPharmaceuticals, #NARCANNasalSprayInc, #Product/ServicesAnnouncementBusiness, #EBS, #Emergent Biosolutions Inc, #Major Pharmaceutical Preparations
Share this article:
Link copied to clipboard.

Comments

Comments are available to active subscribers. Subscribe or Log in.
Get the full CSIMarket dataset: Subscribe API License